KOAN — Apollo Biowellness Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapValue Trap

Annual cashflow statement for Apollo Biowellness, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	R2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K/A	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-3.51	-1.94	-5.76	0.654	-1.42
Depreciation
Non-Cash Items	2.72	0.77	3.18	-2.27	0.772
Discontinued Operations
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	—	-0.21	-0.379	0.178	0.646
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Payable / Accrued Expenses
Other Operating Cash Flow
Cash from Operating Activities	-0.791	-1.38	-2.95	-1.43	0.011
Capital Expenditures	—	—	-0.036	0	—
Purchase of Fixed Assets
Other Investing Cash Flow Items	-0.025	0	—	—	-0.805
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-0.025	0	-0.036	0	-0.805
Financing Cash Flow Items	0.611	1.01	1.38	0.091	-0.085
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	0.819	1.49	2.88	1.48	0.736
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	0.003	0.111	-0.101	0.052	-0.057